Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.
Rutgers School of Dental Medicine is an ADA CERP Recognized Provider; the current term of acceptance extends to 6/21. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the CE provider or to ADA CERP at www.ada.org/cerp.
The Rutgers School of Dental Medicine (RSDM) designates this activity for 1.5 continuing education credits.
Acknowledgment of Support
This activity is supported by educational grants from Amgen Inc.
Clinical Consultations™: Improving the Coordination of Care Between Dentists, Oral Surgeons, and Osteoporosis Specialists to Reduce the Risk of ONJ
Release Date: February 26, 2021
Expiration Date: February 26, 2022
Activity Overview
Every day, a fracture due to osteoporosis occurs every 3 seconds around the world, with the characteristic fractures at the spine and hip leading to substantial mortality, morbidity, and huge societal costs worldwide. After the age of 50 years, 1 in 3 women and 1 in 5 men will experience a fragility fracture. Therapeutic options for the treatment of osteoporosis, including bisphosphonates and denosumab, are essential to reduce the significant morbidity and mortality associated with the disease. However, osteonecrosis of the jaw (ONJ) is a relatively rare but potentially serious and painful debilitating complication of antiresorptive agents that can considerably affect the quality of life of affected patients. There is a gap in care between dentists and physicians in coordinating the management of their patients with osteoporosis, who need dental review before starting osteoporosis treatments, and their management of patients with ONJ.
This activity is aimed to improve clinicians’ knowledge about the incidence and risk of ONJ associated with antiresorptive therapies, and present guideline-recommended strategies on how to optimize treatment and mitigate the risk for ONJ to improve clinical outcomes for patients affected by this widely prevalent disease. In addition, strategies to coordinate communication among the disciplines caring for at-risk patients will also be reviewed.
Acknowledgement of Commercial Support
This activity is supported by educational grants from Amgen Inc.
Instructions for This Activity and Receiving Credit
You may immediately download your certificate. |
Target Audience
This activity is intended for community endocrinologists, dentists, oral surgeons, rheumatologists, primary care clinicians, nurse practitioners, physician assistants, nurses and other HCPs involved in the management of osteoporosis and ONJ. This activity will provide education to a broad multidisciplinary team who will be invited to participate.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Recognize and appropriately manage patients at risk for osteonecrosis of the jaw (ONJ)
- Evaluate efficacy and safety of agents for the treatment of patients with osteoporosis and their impact on ONJ risk
- Integrate a multidisciplinary approach to the management of patients with osteoporosis
Faculty, Staff, and Planners’ Disclosures
In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Faculty
Clinical Associate Professor
Department of Oral and Maxillofacial Surgery
Rutgers School of Dental Medicine
Newark, NJ
Disclosures: Pamela L. Alberto, DMD, has no relevant financial relationships with commercial interests to disclose.
Silberberg Professor of Medicine
Vice-Chair, Department of Medicine, International Education and Research
Vagelos College of Physicians & Surgeons
Columbia University
New York, NY
Disclosures: Grant/Research Support: Abiogen, NIH; Consultant: Abiogen, Amgen, Amolyt, Radius; Speaker’s Bureau: Amgen, Radius; Other: (Data and Safety Monitoring Board) Regeneron.
Assistant Professor
Department of Diagnostic Sciences
Rutgers School of Dental Medicine
Newark, NJ
Disclosures: Gayathri Subramanian, BDS, DMD, PhD, has no relevant financial relationships with commercial interests to disclose.
The staff of Physicians’ Education Resource®, LLC (PER®), have no relevant financial relationships with commercial interests to disclose.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
Login or Register to Start Activity
Please use the form below to Register or Log In to begin Activity.
